Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J Schnitt

Showing results (91-100 of 232) with videos related to

Pageof 24
Sort By:
Annals of Surgical Oncology|June 30, 2022
Presence of Non-classic LCIS Is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCISFaina Nakhlis, Fisher D Katlin, Samantha C Grossmith, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 21, 2005
Early life factors and incidence of proliferative benign breast diseaseHeather J Baer, Stuart J Schnitt, James L Connolly, et al.
Breast Cancer Research : BCR|July 1, 2005
Benign breast disease, recent alcohol consumption, and risk of breast cancer: a nested case-control studyRulla M Tamimi, Celia Byrne, Heather J Baer, et al.
Annals of Surgical Oncology|July 9, 2022
Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I-III Breast CancerAlison Laws, Ricardo Pastorello, Tanujit Dey, et al.
Breast Cancer Research and Treatment|September 9, 2016
A prospective study of endometriosis and risk of benign breast diseaseLeslie V Farland, Rulla M Tamimi, A Heather Eliassen, et al.
International Journal of Cancer|July 13, 2002
Family history of breast cancer, age and benign breast diseasePenelope M Webb, Celia Byrne, Stuart J Schnitt, et al.
Breast Cancer Research and Treatment|July 6, 2011
COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirinMichelle D Holmes, Wendy Y Chen, Stuart J Schnitt, et al.
Breast Cancer Research and Treatment|March 11, 2011
The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health StudyYing Liu, Rulla M Tamimi, Laura C Collins, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 15, 2020
Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterationsBeth T Harrison, Faina Nakhlis, Deborah A Dillon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 21, 2020
Clinico-pathologic predictors of patterns of residual disease following neoadjuvant chemotherapy for breast cancerRicardo G Pastorello, Alison Laws, Samantha Grossmith, et al.
Pageof 24

Showing results (91-100 of 232) with videos related to

Sort By:
Pageof 24
Annals of Surgical Oncology|June 30, 2022
Presence of Non-classic LCIS Is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCISFaina Nakhlis, Fisher D Katlin, Samantha C Grossmith, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 21, 2005
Early life factors and incidence of proliferative benign breast diseaseHeather J Baer, Stuart J Schnitt, James L Connolly, et al.
Breast Cancer Research : BCR|July 1, 2005
Benign breast disease, recent alcohol consumption, and risk of breast cancer: a nested case-control studyRulla M Tamimi, Celia Byrne, Heather J Baer, et al.
Annals of Surgical Oncology|July 9, 2022
Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I-III Breast CancerAlison Laws, Ricardo Pastorello, Tanujit Dey, et al.
Breast Cancer Research and Treatment|September 9, 2016
A prospective study of endometriosis and risk of benign breast diseaseLeslie V Farland, Rulla M Tamimi, A Heather Eliassen, et al.
International Journal of Cancer|July 13, 2002
Family history of breast cancer, age and benign breast diseasePenelope M Webb, Celia Byrne, Stuart J Schnitt, et al.
Breast Cancer Research and Treatment|July 6, 2011
COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirinMichelle D Holmes, Wendy Y Chen, Stuart J Schnitt, et al.
Breast Cancer Research and Treatment|March 11, 2011
The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health StudyYing Liu, Rulla M Tamimi, Laura C Collins, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 15, 2020
Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterationsBeth T Harrison, Faina Nakhlis, Deborah A Dillon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 21, 2020
Clinico-pathologic predictors of patterns of residual disease following neoadjuvant chemotherapy for breast cancerRicardo G Pastorello, Alison Laws, Samantha Grossmith, et al.
Pageof 24